Gastric Inflammatory Myofibroblastic Tumor Identified As Ectopic Pancreas and Treated by Endoscopic Submucosal Dissection

Xiaoyan Ning,Biao Liang,Qinyi Liu,Xiaowu Chen,Ming Xu
DOI: https://doi.org/10.1016/j.gie.2017.05.037
IF: 10.396
2017-01-01
Gastrointestinal Endoscopy
Abstract:A 50-year-old woman presented with intermittent epigastric pain for the previous 6 years. She did not describe anorexia, nausea, vomiting, hematemesis, melena, fever, fatigue, or weight loss. Gastroscopy showed a disk-shaped submucosal lesion with an approximate diameter of 3 cm in the gastric antrum (A). The lesion had a superficial depression in the center and was diagnosed as gastric ectopic pancreas on the basis of its appearance. The patient was treated by endoscopic submucosal dissection (ESD). The lesion was excised without difficulty. Histopathologic examination showed that it mainly consisted of spindle cells that had ovoid or fusiform nuclei with small nucleoli (B). Mitosis was not easily found. Congested vessels, redundant lymphocytes, and eosinophil infiltration were also identified in the tissue. Immunohistochemical staining showed Vimentin (+) (C, Vimentin stain, orig. mag. ×100), CD117, CD34, DOG-1, CD10, smooth muscle actin, and S-100 (−) and a Ki-67 label index <1%. The patient received a diagnosis of gastric inflammatory myofibroblastic tumor (IMT), and the abdominal pain disappeared after the lesion was removed. There was no recurrence or metastasis during the 2 years of follow-up. To the best of our knowledge, this is the first case of gastric IMT treated by ESD.
What problem does this paper attempt to address?